Back to results
US 5,847,010 AGranted
Treatment of multiple sclerosis
AssigneeBerlex Laboratories, Inc.
InventorsJoel Hedgpeth, Helmut Wachtel
Life of this patent
Estimating the term…
Abstract
The present invention is a method of preventing or ameliorating the episodic recurrence of MS, comprising administering an effective amount of selective phosphodiesterase inhibitors of Type IV, e.g., Rolipram, e.g., wherein the severity of the episodic recurrences is ameliorated or the time period between episodes is lengthened.
Claims1
An implantable osmotic pump comprising 4-(3-cyclopentyloxy)-4-methoxyphenyl!-2-pyrrolidinone and a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.